Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 31, 2025 06:15 ET | Source: ICPO Foundation

ICPO und SBMN vertiefen ihre Zusammenarbeit zur Förderung von Klinischen Theranostik-Zentren der Exzellenz in Brasilien

Die ICPO-Akkreditierung erfolgt gemäß internationalen Theranostik-Richtlinien, während die ICPO Academy for Theranostics die Partnerschaft von Anfang an stärkt. 31. Juli 2025 – Wiesbaden,...
July 31, 2025 06:15 ET | Source: ICPO Foundation

ICPO and SBMN deepen their collaboration to advance Clinical Theranostics Centers of Excellence in Brazil

ICPO accreditation following international theranostics guidelines and ICPO Academy for Theranostics will fuel the partnership right from start. July 31, 2025 – Wiesbaden, Germany, and Sao Paulo,...
June 21, 2025 06:20 ET | Source: ICPO Foundation

ICPO Foundation ist Co-Founder der RLT Angels Association mit dem Ziel, den Zugang zur Radiotheranostik für eine Million PatientInnen auszubauen

Weitere Gründungsmitglieder sind die European Association of Nuclear Medicine (EANM), GE HealthCare, Novartis und RayzeBio, ein Unternehmen von Bristol Myers Squibb. Wiesbaden, 21. Juni 2025 – Die...
June 21, 2025 06:20 ET | Source: ICPO Foundation

ICPO Foundation co-founded the RLT Angels Association with the aim of growing access to Radiotheranostics to one million patients

Further founding members include the European Association of Nuclear Medicine (EANM), GE HealthCare, Novartis, and RayzeBio, a Bristol Myers Squibb company. Wiesbaden, June 21, 2025 – The...
January 09, 2025 05:00 ET | Source: Primo Biotechnology Co., Ltd.

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
January 08, 2025 21:00 ET | Source: Primo Biotechnology Co., Ltd.

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
January 08, 2025 20:00 ET | Source: Primo Biotechnology Co., Ltd.

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.
January 08, 2025 10:00 ET | Source: Primo Biotechnology Co., Ltd.

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific

Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.